These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24155855)

  • 1. Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic.
    Donaldson M; Norbeck AO
    Pharm Pract (Granada); 2013 Apr; 11(2):90-5. PubMed ID: 24155855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
    Garnock-Jones KP
    Am J Cardiovasc Drugs; 2011; 11(1):57-72. PubMed ID: 21265583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology and therapeutic use of dabigatran etexilate.
    Sarah S
    J Clin Pharmacol; 2013 Jan; 53(1):1-13. PubMed ID: 23400738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemopericardium in a patient treated with dabigatran etexilate.
    Barton CA; McMillian WD; Raza SS; Keller RE
    Pharmacotherapy; 2012 May; 32(5):e103-7. PubMed ID: 22488474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
    Baetz BE; Spinler SA
    Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dabigatran etexilate: A novel oral direct thrombin inhibitor.
    Blommel ML; Blommel AL
    Am J Health Syst Pharm; 2011 Aug; 68(16):1506-19. PubMed ID: 21817082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.
    Ma TK; Yan BP; Lam YY
    Pharmacol Ther; 2011 Feb; 129(2):185-94. PubMed ID: 20920530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
    Burness CB; McKeage K
    Drugs; 2012 May; 72(7):963-86. PubMed ID: 22564134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
    Dans AL; Connolly SJ; Wallentin L; Yang S; Nakamya J; Brueckmann M; Ezekowitz M; Oldgren J; Eikelboom JW; Reilly PA; Yusuf S
    Circulation; 2013 Feb; 127(5):634-40. PubMed ID: 23271794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.
    Blair HA; Keating GM
    Drugs; 2017 Mar; 77(3):331-344. PubMed ID: 28185082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
    Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
    J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
    McKellar SH; Abel S; Camp CL; Suri RM; Ereth MH; Schaff HV
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1410-6. PubMed ID: 21429525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.
    Bovio JA; Smith SM; Gums JG
    Ann Pharmacother; 2011 May; 45(5):603-14. PubMed ID: 21540406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.
    Ferro JM; Coutinho JM; Dentali F; Kobayashi A; Alasheev A; Canhão P; Karpov D; Nagel S; Posthuma L; Roriz JM; Caria J; Frässdorf M; Huisman H; Reilly P; Diener HC;
    JAMA Neurol; 2019 Dec; 76(12):1457-1465. PubMed ID: 31479105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
    Garnock-Jones KP
    Drugs Aging; 2011 May; 28(5):415-9. PubMed ID: 21542663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.
    Meyer Dos Santos S; Harder S
    Drug Saf; 2014 May; 37(5):295-307. PubMed ID: 24683059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
    Glund S; Stangier J; Schmohl M; Gansser D; Norris S; van Ryn J; Lang B; Ramael S; Moschetti V; Gruenenfelder F; Reilly P; Kreuzer J
    Lancet; 2015 Aug; 386(9994):680-90. PubMed ID: 26088268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation.
    Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    Clin Drug Investig; 2013 Jun; 33(6):409-18. PubMed ID: 23572324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarin.
    Tran A; Cheng-Lai A
    Cardiol Rev; 2011; 19(3):154-61. PubMed ID: 21464643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.
    Dzeshka MS; Lip GY
    Expert Opin Drug Saf; 2015 Jan; 14(1):45-62. PubMed ID: 25341529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.